Table 1. Quadrivalent Meningococcal Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Quadrivalent Meningococcal Vaccine Market Restraints

Table 3. Quadrivalent Meningococcal Vaccine Market Trends

Table 4. Quadrivalent Meningococcal Vaccine Industry Policy

Table 5. Global Quadrivalent Meningococcal Vaccine Revenue by Company, 2018-2023, US$ million

Table 6. Global Quadrivalent Meningococcal Vaccine Revenue Market Share by Company, 2018-2023

Table 7. Global Quadrivalent Meningococcal Vaccine Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share by Company, 2018-2023

Table 9. Global Quadrivalent Meningococcal Vaccine Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Quadrivalent Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Quadrivalent Meningococcal Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Quadrivalent Meningococcal Vaccine Manufacturers Product Type

Table 13. China Quadrivalent Meningococcal Vaccine Revenue by Company, 2018-2023, US$ million

Table 14. China Quadrivalent Meningococcal Vaccine Revenue Market Share by Company, 2018-2023

Table 15. China Quadrivalent Meningococcal Vaccine Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Quadrivalent Meningococcal Vaccine Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Quadrivalent Meningococcal Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Quadrivalent Meningococcal Vaccine Import & Export Trends

Table 19. Main Sources of China Quadrivalent Meningococcal Vaccine Import

Table 20. Export Destination of China Quadrivalent Meningococcal Vaccine

Table 21. Global Headquarters and Manufacturing Base of Quadrivalent Meningococcal Vaccine Manufacturers

Table 22. Global Major Manufacturers, Quadrivalent Meningococcal Vaccine Capacity Expansion and Future Plans

Table 23. Global Quadrivalent Meningococcal Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Quadrivalent Meningococcal Vaccine Production by Region, 2018-2023, (K Units)

Table 25. Global Quadrivalent Meningococcal Vaccine Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Quadrivalent Meningococcal Vaccine Upstream (Raw Materials)

Table 27. Global Quadrivalent Meningococcal Vaccine Typical Customers

Table 28. Quadrivalent Meningococcal Vaccine Typical Distributors

Table 29. By Type, Global Quadrivalent Meningococcal Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Quadrivalent Meningococcal Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Quadrivalent Meningococcal Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Quadrivalent Meningococcal Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029

Table 37. By Country, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2018-2029

Table 39. Sanofi-Pasteur Company Information, Head Office, Market Area and Industry Position

Table 40. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 41. Sanofi-Pasteur Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Sanofi-Pasteur Company Profile and Main Business

Table 43. Sanofi-Pasteur Recent Developments

Table 44. Walvax Company Information, Head Office, Market Area and Industry Position

Table 45. Walvax Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 46. Walvax Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Walvax Company Profile and Main Business

Table 48. Walvax Recent Developments

Table 49. Chengdu Kanghua Biological Products Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 50. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 51. Chengdu Kanghua Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Chengdu Kanghua Biological Products Co., Ltd. Company Profile and Main Business

Table 53. Chengdu Kanghua Biological Products Co., Ltd. Recent Developments

Table 54. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 55. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 56. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Company Profile and Main Business

Table 58. Beijing Zhifei Green Bamboo Biopharmaceutical Co., Ltd. Recent Developments

Table 59. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 60. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 61. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Company Profile and Main Business

Table 63. Zhejiang Tianyuan Biopharmaceutical Co., Ltd. Recent Developments

Table 64. Beijing Institute of Biological Products Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 65. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 66. Beijing Institute of Biological Products Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Beijing Institute of Biological Products Co., Ltd. Company Profile and Main Business

Table 68. Beijing Institute of Biological Products Co., Ltd. Recent Developments

Table 69. CanSino Biological Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 70. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 71. CanSino Biological Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. CanSino Biological Co., Ltd. Company Profile and Main Business

Table 73. CanSino Biological Co., Ltd. Recent Developments

Table 74. Hualan Biological Vaccine Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 75. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 76. Hualan Biological Vaccine Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Hualan Biological Vaccine Co., Ltd. Company Profile and Main Business

Table 78. Hualan Biological Vaccine Co., Ltd. Recent Developments

Table 79. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 80. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Models, Specifications and Application

Table 81. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Quadrivalent Meningococcal Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Company Profile and Main Business

Table 83. Amy Weixin Biopharmaceutical (Zhejiang) Co., Ltd. Recent Developments

List of Figure

Figure 1. Quadrivalent Meningococcal Vaccine Picture

Figure 2. By Revenue, Global Quadrivalent Meningococcal Vaccine Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Quadrivalent Meningococcal Vaccine Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Quadrivalent Meningococcal Vaccine Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Quadrivalent Meningococcal Vaccine Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Quadrivalent Meningococcal Vaccine Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Quadrivalent Meningococcal Vaccine Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Quadrivalent Meningococcal Vaccine Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Quadrivalent Meningococcal Vaccine Share of Global Market, 2018-2029

Figure 10. Global Quadrivalent Meningococcal Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Quadrivalent Meningococcal Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Quadrivalent Meningococcal Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Quadrivalent Meningococcal Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Quadrivalent Meningococcal Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Quadrivalent Meningococcal Vaccine Domestic VS Export, 2022

Figure 16. Global Quadrivalent Meningococcal Vaccine Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Quadrivalent Meningococcal Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Quadrivalent Meningococcal Vaccine Production Market Share & Forecast by Region, 2018-2029

Figure 19. Quadrivalent Meningococcal Vaccine Industry Chain

Figure 20. Quadrivalent Meningococcal Vaccine Procurement Model

Figure 21. Quadrivalent Meningococcal Vaccine Sales Model

Figure 22. Quadrivalent Meningococcal Vaccine Sales Channels, Direct Sales and Distribution

Figure 23. Polysaccharide Vaccine

Figure 24. Conjugate Vaccine

Figure 25. By Type, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029

Figure 27. By Type, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Quadrivalent Meningococcal Vaccine Price, 2018-2029, (US$/Unit)

Figure 30. Hospital

Figure 31. Clinic

Figure 32. By Application, Global Quadrivalent Meningococcal Vaccine Revenue, 2018-2029, US$ Million

Figure 33. By Application, Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029

Figure 34. By Application, Global Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 35. By Application, Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2018-2029

Figure 36. By Application, Global Quadrivalent Meningococcal Vaccine Price, 2018-2029, (US$/Unit)

Figure 37. By Region, Global Quadrivalent Meningococcal Vaccine Revenue Market Share, 2018-2029

Figure 38. By Region, Global Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2018-2029

Figure 39. North America Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 40. By Country, North America Quadrivalent Meningococcal Vaccine Revenue Market Share, 2022

Figure 41. Europe Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 42. By Country, Europe Quadrivalent Meningococcal Vaccine Revenue Market Share, 2022

Figure 43. Asia Pacific Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 44. By Country/Region, Asia Pacific Quadrivalent Meningococcal Vaccine Revenue Market Share, 2022

Figure 45. South America Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 46. By Country, South America Quadrivalent Meningococcal Vaccine Revenue Market Share, 2022

Figure 47. Middle East & Africa Quadrivalent Meningococcal Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 48. U.S. Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 49. By Company, U.S. Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 50. By Type, U.S. Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 51. By Application, U.S. Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 52. Europe Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 53. By Company, Europe Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 54. By Type, Europe Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 55. By Application, Europe Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 56. China Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 57. By Company, China Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 58. By Type, China Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 59. By Application, China Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 60. Japan Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 61. By Company, Japan Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 62. By Type, Japan Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 63. By Application, Japan Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 64. South Korea Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 65. By Company, South Korea Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 66. By Type, South Korea Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 67. By Application, South Korea Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 68. Southeast Asia Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 69. By Company, Southeast Asia Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 70. By Type, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 71. By Application, Southeast Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 72. India Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 73. By Company, India Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 74. By Type, India Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 75. By Application, India Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 76. Middle East & Asia Quadrivalent Meningococcal Vaccine Sales Volume, 2018-2029, (K Units)

Figure 77. By Company, Middle East & Asia Quadrivalent Meningococcal Vaccine Market Share, 2022

Figure 78. By Type, Middle East & Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 79. By Application, Middle East & Asia Quadrivalent Meningococcal Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 80. Research Methodology

Figure 81. Breakdown of Primary Interviews

Figure 82. Bottom-up Approaches

Figure 83. Top-down Approaches